TY - JOUR
T1 - Killing of Serratia marcescens biofilms with chloramphenicol
AU - Ray, Christopher
AU - Shenoy, Anukul T.
AU - Orihuela, Carlos J.
AU - González-Juarbe, Norberto
N1 - Funding Information:
N.G.J. was supported by National Institutes for Health Immunologic Diseases and Basic Immunology Grant 5T32AI007051‑38. C.J.O. was funded by National Institutes for Health Grant AI114800.
Publisher Copyright:
© 2017 The Author(s).
PY - 2017/3/29
Y1 - 2017/3/29
N2 - Serratia marcescens is a Gram-negative bacterium with proven resistance to multiple antibiotics and causative of catheter-associated infections. Bacterial colonization of catheters mainly involves the formation of biofilm. The objectives of this study were to explore the susceptibility of S. marcescens biofilms to high doses of common antibiotics and non-antimicrobial agents. Biofilms formed by a clinical isolate of S. marcescens were treated with ceftriaxone, kanamycin, gentamicin, and chloramphenicol at doses corresponding to 10, 100 and 1000 times their planktonic minimum inhibitory concentration. In addition, biofilms were also treated with chemical compounds such as polysorbate-80 and ursolic acid. S. marcescens demonstrated susceptibility to ceftriaxone, kanamycin, gentamicin, and chloramphenicol in its planktonic form, however, only chloramphenicol reduced both biofilm biomass and biofilm viability. Polysorbate-80 and ursolic acid had minimal to no effect on either planktonic and biofilm grown S. marcescens. Our results suggest that supratherapeutic doses of chloramphenicol can be used effectively against established S. marcescens biofilms.
AB - Serratia marcescens is a Gram-negative bacterium with proven resistance to multiple antibiotics and causative of catheter-associated infections. Bacterial colonization of catheters mainly involves the formation of biofilm. The objectives of this study were to explore the susceptibility of S. marcescens biofilms to high doses of common antibiotics and non-antimicrobial agents. Biofilms formed by a clinical isolate of S. marcescens were treated with ceftriaxone, kanamycin, gentamicin, and chloramphenicol at doses corresponding to 10, 100 and 1000 times their planktonic minimum inhibitory concentration. In addition, biofilms were also treated with chemical compounds such as polysorbate-80 and ursolic acid. S. marcescens demonstrated susceptibility to ceftriaxone, kanamycin, gentamicin, and chloramphenicol in its planktonic form, however, only chloramphenicol reduced both biofilm biomass and biofilm viability. Polysorbate-80 and ursolic acid had minimal to no effect on either planktonic and biofilm grown S. marcescens. Our results suggest that supratherapeutic doses of chloramphenicol can be used effectively against established S. marcescens biofilms.
KW - Antibiotics
KW - Biofilm
KW - Chloramphenicol
KW - Serratia marcescens
UR - http://www.scopus.com/inward/record.url?scp=85016518050&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85016518050&partnerID=8YFLogxK
U2 - 10.1186/s12941-017-0192-2
DO - 10.1186/s12941-017-0192-2
M3 - Article
C2 - 28356113
AN - SCOPUS:85016518050
VL - 16
JO - Annals of Clinical Microbiology and Antimicrobials
JF - Annals of Clinical Microbiology and Antimicrobials
SN - 1476-0711
IS - 1
M1 - 19
ER -